MedWatch

Troubled Coloplast division has Greece to itself

The latest financial report from Coloplast took a hit from a source far away from home, namely a price reform in Greece. According to the CEO, Greece has become an important market for the company’s skin- and wound care division because there is almost no competition in the Southern European country.

Foto: Niels Hougaard

The accounts of Danish life science companies are rarely affected by events in Greece.

However, this is the case of Coloplast’s Q1 interim report.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier